Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment Due to Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05544201
What this trial is testing

Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease

Who this might be right for
Brain StimulationAlzheimer DiseasetACS+3 more
Chinese University of Hong Kong 99
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Not applicableUnknownNCT05732519
What this trial is testing

Turkish Speech Analysis Development Study

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
mihrimah ozturk 180
Testing effectiveness (Phase 2)UnknownNCT04141150
What this trial is testing

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics, LLC 130
Testing effectiveness (Phase 2)WithdrawnNCT02667496
What this trial is testing

Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Dementia Alzheimer's Type
Sanofi
Not applicableStudy completedNCT04049643
What this trial is testing

Hearing Aid and Individuals With Cognitive Disorders

Who this might be right for
Presbycusis, BilateralAlzheimer Disease 2 Due to Apoe4 IsoformMild Cognitive Impairment
Yu-Hsiang Wu 17
Early research (Phase 1)Study completedNCT01600859
What this trial is testing

Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)

Who this might be right for
Alzheimer's Disease
Eisai Inc. 65
Testing effectiveness (Phase 2)Study completedNCT03061474
What this trial is testing

Nicotinamide as an Early Alzheimer's Disease Treatment

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
University of California, Irvine 46
Testing effectiveness (Phase 2)Study completedNCT02702817
What this trial is testing

Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseCognitive Decline Due to Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer Disease
Douglas Mental Health University Institute 200
Not applicableLooking for participantsNCT07334392
What this trial is testing

Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentWalkingBalance+1 more
University of Patras 45
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Testing effectiveness (Phase 2)Ended earlyNCT04795466
What this trial is testing

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT04191486
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Mild Cognitive Impairment
FUJIFILM Toyama Chemical Co., Ltd. 221
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Early research (Phase 1)Ended earlyNCT02573740
What this trial is testing

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
AbbVie 8
Not applicableLooking for participantsNCT07768579
What this trial is testing

The Effect of Sequential Therapy on Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer DiseaseAlzheimer Disease
Dongzhimen Hospital, Beijing 600
Testing effectiveness (Phase 2)Ended earlyNCT03639987
What this trial is testing

Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

Who this might be right for
Cognitive DysfunctionAlzheimer's Disease
Biogen 52
Next Page